Newsroom

News

Compound repurposing is an important strategy for the identification of effective treatment options against SARS-CoV-2 infection and COVID-19 disease.The EU-OPENSCREEN high capacity screening partner…

Read more

If you are interested in 3D in vitro models and drug discovery do not miss our recent publication “Academic collaborative models fostering the translation of physiological in vitro systems from basic…

Read more

It is our pleasure to welcome you to the European Chemical Biology Symposium (ECBS) 2021, May 26-28, which is jointly organised by EU-OPENSCREEN and the EuChemS Division of Chemistry for Life Sciences…

Read more

EU-OPENSCREEN is looking for video content producers for the production of image and target group oriented content.

Read more

With more than 170 participants from the ERIC/RI communities, ESFRI, European Commission and more, the ERIC Forum 2021 was a great opportunity for timely and fruitful discussions on high-level science…

Read more

EU-OPENSCREEN Director General, Wolfgang Fecke, will continue to support the work of the Executive Board for the life sciences cluster, Franciska de Jong, Executive Director, CLARIN ERIC, for the…

Read more

The European Commission has launched a manifesto to maximise the accessibility of research results in the fight against COVID-19. The manifesto provides guiding principles for beneficiaries of EU…

Read more

We are proud to welcome the Translational Medicinal and Biological Chemistry Laboratory headed by Prof. Ana Martinez, at the Margarita Salas Center for Biological Research (Centro de Investigaciones…

Read more

In FBDD low-molecular-weight fragments (<250 Da) are screened using structural biology and biophysical techniques to identify hits, which commonly have lower binding affinities (in the range of…

Read more

After the inclusion of EU-OPENSCREEN in the Romanian Roadmap for Research Infrastructures, we are pleased about another major success in Romania: Our partner the Coriolan Dragulescu Institute of…

Read more